Hematogenous extramedullary relapse in multiple myeloma ‐ a multicenter retrospective study in 127 patients-Reference-Cited by-同舟云学术

Hematogenous extramedullary relapse in multiple myeloma ‐ a multicenter retrospective study in 127 patients

Published:2019-08-13 Issue:10 Volume:94 Page:1132-1140
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Avivi Irit¹,Cohen Yael C.¹^ORCID,Suska Anna²,Shragai Tamir³,Mikala Gabor³,Garderet Laurent⁴⁵^ORCID,Seny Gueye M.⁴,Glickman Sophia⁶,Jayabalan David S.⁶,Niesvizky Ruben⁶,Gozzetti Alessandro⁷,Wiśniewska‐Piąty Katarzyna⁸,Waszczuk‐Gajda Anna⁹^ORCID,Usnarska‐Zubkiewicz Lidia¹⁰,Hus Iwona¹¹,Guzicka Renata¹²,Radocha Jakub¹³^ORCID,Milunovic Vibor¹⁴,Davila Julio¹⁵,Gentile Massimo¹⁶,Castillo Jorge J.¹⁷,Jurczyszyn Artur²^ORCID

Affiliation:

1. Tel Aviv Medical Center and Sackler Faculty of Medicine Tel Aviv Israel

2. Department of HematologyJagiellonian University Medical College Cracow Poland

3. Department of Hematology and Stem Cell TransplantationSouth‐Pest Central Hospital, Natl. Inst. Hematol. Infectol Budapest Hungary

4. Service d'Hématologie et thérapie cellulaireHôpital Saint Antoine Paris France

5. Service d'HématologieHôpital Pitié Salpêtrière Paris France

6. Weill Cornell Medical College New York New York

7. Le Scotte Hospital Siena Italy

8. Department of Haematology and Bone Marrow TransplantationSilesian Medical University Katowice Poland

9. Department of Hematology, Oncology and Internal DiseasesWarsaw Medical University Warsaw Poland

10. Department of Hematology, Blood Neoplasms and Bone Marrow TransplantationWroclaw Medical University Poland

11. Department of Haematology and Bone Marrow TransplantationMedical University of Lublin Lublin Poland

12. Department of HaematologyPomeranian Medical University Szczecin Poland

13. 4th Department of Medicine – HaematologyCharles University Hospital Hradec Kralove Hradec Kralove Czech Republic

14. Division of HematologyClinical Hospital Merkur Zagreb Croatia

15. Asistencial de Avila Hospital Ávila Spain

16. Hematology Unit, Department of Onco‐HematologyAzienda Ospendaliera of Cosenza Cosenza Italy

17. Dana‐Farber Cancer InstituteHarvard Medical School Boston Massachusetts

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25579

Reference35 articles.

1. How I treat extramedullary myeloma

2. Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse

3. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

4. Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

5. Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study;Annals of Hematology;2024-01-11

2. Not Your Everyday Duodenal Ulcer: Massive Gastrointestinal Bleed Secondary to Extramedullary Plasma Cell Myeloma;ACG Case Reports Journal;2023-04

3. Updates on Multiple Myeloma: What’s New in Risk Stratification, Treatment, and Prognosis;Recent Updates on Multiple Myeloma;2023-03-15

4. Treatment of Multiple Myeloma in the First Relapse;Recent Updates on Multiple Myeloma;2023-03-15

5. EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress;Blood Advances;2023-02-16